Skip to content
Open access

Incidence, Prevalence, Mortality, and Disability‐Adjusted Life Years Due to Cancer Among Adolescents Aged 10–19 Years in Iran, 1990–2023: A Trend Analysis of the Global Burden of Disease Study

Nov 2026 · Health Science Reports · Vol 9 · 0 citations · 34 references
Medicine

TL;DR

The concurrent increase in incidence and, particularly, YLDs suggests an epidemiological shift toward a greater nonfatal burden among Iranian adolescents and supports the need for comprehensive survivorship care and stronger cancer registration and surveillance systems to address emerging challenges in adolescent oncology.

Abstract

ABSTRACT Background and Aims Cancer remains a major global public health challenge; however, epidemiological data on the cancer burden among Iranian adolescents remain limited. This study aimed to assess incidence, prevalence, mortality, and disability‐adjusted life years (DALYs) due to cancer among individuals aged 10–19 years in Iran from 1990 to 2023. Methods This trend analysis used data from the Global Burden of Disease (GBD) 2023 study. Extracted indicators included incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and DALYs, expressed as age‐standardized rates per 100,000 populations. Temporal trends were evaluated using joinpoints regression, and average annual percent changes (AAPCs) with 95% confidence intervals (CIs) were calculated. Results During 1990–2023, 52,942 cancer deaths occurred among Iranian adolescents, including 26,662 (50.4%) in females. Leukemia, brain and central nervous system cancers, and other malignant neoplasms were the leading causes of death. Incidence showed a small but statistically significant increase (AAPC, 0.1; 95% CI, 0.0–0.2 for both sexes), whereas mortality declined (AAPC, −1.2; 95% CI, −1.3 to −1.1), as did DALY rates (AAPC, −1.1; 95% CI, −1.2 to −1.0). In contrast, YLD rates increased substantially (AAPC, 2.0; 95% CI, 1.9–2.1). Non‐Hodgkin lymphoma showed increasing trends in mortality and DALYs. Conclusion Although mortality and the overall cancer burden among Iranian adolescents have declined significantly, the concurrent increase in incidence and, particularly, YLDs suggests an epidemiological shift toward a greater nonfatal burden. These findings support the need for comprehensive survivorship care and stronger cancer registration and surveillance systems to address emerging challenges in adolescent oncology.

Read PDF

Similar papers

Open access Oct 2026

Trends in Breast Cancer Incidence and Mortality Among Iranian Women Aged 30–69 Years and GBD-Attributable Risk Burden: An Ecological Age–Period–Cohort Analysis

Introduction: Breast cancer is the most common malignancy among Iranian women, with shifting epidemiological patterns. This study aimed to analyze age-period-cohort (APC) effects on breast cancer incidence and mortality among Iranian women aged 30– 69 years and assess temporal trends in attributable risk factors. Metho...

Rasoul Gholamiveis, Z. Shaahmadi, F. Heydarpour et al. · 0 citations
Open access Oct 2026

Global, regional and national cancer burden and trends of middle-aged and older populations: a GBD 2021-based analysis, prediction and prevention

Background Middle-aged and older adults (MAOs; defined as individuals aged ≥40 years) account for the global cancer burden, contributing to 70–80% of cases. Characterizing cancer profiles in this demographic is essential for developing targeted prevention and treatment strategies to mitigate global impacts. Methods Usi...

Ruo-Kai Sun, Feng Shi, Yin-Si Tang et al. · 0 citations
Open access Oct 2026

Global, Regional, and National Burden of Early-Onset Breast Cancer in Women, 1990–2021: GBD 2021 Analysis of Trends, Modifiable Risk Factors, and Health Inequalities

Background Early-onset breast cancer (EOBC) affects women aged 15–44 years during reproductive and economically active life stages. We quantified global, regional, and national EOBC burden from 1990 to 2021, including temporal inflection points, modifiable risks, and health inequalities. Methods Using Global Burden of...

Xing-Tong Zhou, Xiao-Ying Zhong, Mo-Han Liu et al. · 0 citations
Open access Sep 2026

Global burdens of diabetes mellitus in adolescents from 1990 to 2023 and future trend predictions: An analysis of the Global Burden of Disease study 2023

The burden of adolescent DM increased considerably from 1990 to 2023, with marked heterogeneity by age, sex, and geography, and ARIMA forecasts indicate that ASIR, ASPR, and ASDR are projected to continue increasing through 2040, while ASMR is expected to remain low and stable.

Xin-Yi Qiu, Li-Mei Guan, Hui Liu · 0 citations
Sep 2026

Long-Term Trends in Breast Cancer Burden among Women in Korea, 1990–2023: A Secondary Analysis of GBD 2023

This study examined long-term trends in breast cancer burden and changes in the composition of disability-adjusted life years (DALYs) among women in Korea from 1990 to 2023 using data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2023. Absolute numbers and age-standardized rates were assessed for...

Do-Young Lee · 0 citations
Open access Oct 2026

Age-Standardized Disability-Adjusted Life Years (DALYs) of Colorectal Cancer in Brunei Darussalam, 2002–2020: A Population-Based Registry Study

These registry-based estimates, which are broadly comparable with GBD modelled estimates, provide a baseline for monitoring CRC burden and would strengthen future estimates and evaluation of the national screening programme.

Ummi Salwa Suhaimei, H. Tun, E. Leong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.